Inventor · disambiguated record
Jonathan Rios-Doria
Also filed as: RIOS-DORIA JONATHAN
7 granted patents·8 pending applications·40 citations·filing 2008–2024
82Inventor score
Top patents by PatentIndex Score
15 records- 0194US9938356B2Binding molecules specific for CD73 and uses thereofMEDIMMUNE LTD·Filed 2015·Granted Apr 10, 2018·26 cites·9 claims
- 0291US10287362B2Binding molecules specific for CD73 and uses thereofMEDIMMUNE LTD·Filed 2018·Granted May 14, 2019·10 cites·15 claims
- 0384US12214036B2Combination therapy comprising AXL/MER and PD-1/PD-L1 inhibitorsINCYTE CORP·Filed 2021·Granted Feb 4, 2025·1 cites·17 claims
- 0481US10556968B2Binding molecules specific for CD73 and uses thereofMEDIMMUNE LTD·Filed 2019·Granted Feb 11, 2020·2 cites·8 claims
- 0579US2023340152A1Binding molecules specific for cd73 and uses thereofMEDIMMUNE LTD·Filed 2022·Application pending·0 cites
- 0677US8524784B2Polymer micelles containing anthracylines for the treatment of cancerSILL KEVIN N·Filed 2010·Granted Sep 3, 2013·1 cites·11 claims
- 0774US2025228936A1Combination therapy comprising axl/mer and pd-1/pd-l1 inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 0872US11525012B2Binding molecules specific for CD73 and uses thereofMEDIMMUNE LTD·Filed 2019·Granted Dec 13, 2022·0 cites·6 claims
- 0963US2022211864A1Antibody-drug conjugates with immune-mediated therapy agentsMEDIMMUNE LTD·Filed 2021·Application pending·0 cites
- 1059US2009110662A1Modification of biological targeting groups for the treatment of cancerINTEZYNE TECHNOLOGIES INC·Filed 2008·Application pending·0 cites
- 1157US2023226040A1Combination therapy comprising an fgfr inhibitor and a kras inhibitorINCYTE CORP·Filed 2022·Application pending·0 cites
- 1245US2020023072A1Antibody-drug conjugates with immune-mediated therapy agentsMEDIMMUNE LTD·Filed 2017·Application pending·0 cites
- 1339US2010278932A1Polymer micelles containing sn-38 for the treatment of cancerINTEZYNE TECHNOLOGIES INC·Filed 2010·Application pending·0 cites
- 1438US2019076452A1Therapeutic combinations for treating neoplasiaMEDIMMUNE LTD·Filed 2015·Application pending·0 cites
- 1537US8524783B2Polymer micelles containing anthracylines for the treatment of cancerSILL KEVIN N·Filed 2010·Granted Sep 3, 2013·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →